Replies to post #194749 on Biotech Values

[DewDiligence]

FDA approves Opdivo for second-line non-squamous NSCLC:

http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm466413.htm

The FDA review took only five weeks!

Updated Opdivo label:
http://t.co/3ieHuQy2bu